These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Despotis GJ; Grishaber JE; Goodnough LT Transfusion; 1994 Apr; 34(4):290-6. PubMed ID: 8178325 [TBL] [Abstract][Full Text] [Related]
7. Utility of whole blood hemostatometry using the clot signature analyzer for assessment of hemostasis in cardiac surgery. Faraday N; Guallar E; Sera VA; Bolton ED; Scharpf RB; Cartarius AM; Emery K; Concord J; Kickler TS Anesthesiology; 2002 May; 96(5):1115-22. PubMed ID: 11981151 [TBL] [Abstract][Full Text] [Related]
8. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Miller BE; Mochizuki T; Levy JH; Bailey JM; Tosone SR; Tam VK; Kanter KR Anesth Analg; 1997 Dec; 85(6):1196-202. PubMed ID: 9390579 [TBL] [Abstract][Full Text] [Related]
9. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Shore-Lesserson L; Reich DL; DePerio M Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020 [TBL] [Abstract][Full Text] [Related]
10. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Oliver WC; Beynen FM; Nuttall GA; Schroeder DR; Ereth MH; Dearani JA; Puga FJ Ann Thorac Surg; 2003 May; 75(5):1506-12. PubMed ID: 12735570 [TBL] [Abstract][Full Text] [Related]
11. Management of bleeding complications in redo cardiac operations. Smith CR Ann Thorac Surg; 1998 Apr; 65(4 Suppl):S2-8; discussion S27-8. PubMed ID: 9563396 [TBL] [Abstract][Full Text] [Related]
12. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. Jobes DR; Aitken GL; Shaffer GW J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566 [TBL] [Abstract][Full Text] [Related]
13. Autologous platelet-rich plasmapheresis: risk versus benefit in repeat cardiac operations. Shore-Lesserson L; Reich DL; DePerio M; Silvay G Anesth Analg; 1995 Aug; 81(2):229-35. PubMed ID: 7618707 [TBL] [Abstract][Full Text] [Related]
14. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Despotis GJ; Joist JH; Goodnough LT Clin Chem; 1997 Sep; 43(9):1684-96. PubMed ID: 9299961 [TBL] [Abstract][Full Text] [Related]
15. The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. Consten EC; Henny CP; Eijsman L; Dongelmans DA; van Oers MH J Thorac Cardiovasc Surg; 1996 Jul; 112(1):162-7. PubMed ID: 8691863 [TBL] [Abstract][Full Text] [Related]
16. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Despotis GJ; Levine V; Saleem R; Spitznagel E; Joist JH Lancet; 1999 Jul; 354(9173):106-10. PubMed ID: 10408485 [TBL] [Abstract][Full Text] [Related]
17. On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery. Capraro L; Kuitunen A; Salmenperä M; Kekomäki R Acta Anaesthesiol Scand; 2001 Feb; 45(2):200-6. PubMed ID: 11167166 [TBL] [Abstract][Full Text] [Related]
18. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444 [TBL] [Abstract][Full Text] [Related]